U.S. Vessel Sealing Devices Market Size, Share & COVID-19 Impact Analysis, By Product (Electro-Thermal Vessel Sealer Devices {Bipolar Devices and Monopolar Devices}, Ultra Coagulation Shears, and Hybrid), By Components (Generators, Instruments, and Accessories), By Surgery Type (General Surgery and Laparoscopic Surgery), By Application (Urology, Gynecology, Cardiothoracic, Gastroenterology, and Others), By End-user (Hospitals & ASCs, Specialty Clinics, and Others), and Country Forecast, 2023-2030

The U.S. vessel sealing devices market was worth USD 699.7 million in 2022 and is anticipated to grow at a CAGR of 7.1% during the forecast period. 

Vessel sealing devices are used in laparoscopic and open surgeries to facilitate dissection and hemostasis of blood vessels. These devices enable surgeons to improve the efficiency and safety of procedures by reducing blood loss and overall operative time. Along with this, certain other advantages associated with vessel sealing devices are reduced thermal injury to surrounding tissues, high-quality sealing of vessels, and others.

The increasing number of surgical procedures and preferential shift toward minimally-invasive and robotic-assisted surgical procedures are further resulting in the growing adoption of vessel sealing devices among surgeons. According to an article published by the National Center for Biotechnology Information (NCBI), it was reported that about 9.6 million inpatient surgeries were performed in the U.S. in 2018. Amongst these, 11.2% were minimally invasive surgeries, and 2.9% were robotic-assisted surgeries among patients.

However, the impact of COVID-19 on the market was negative in 2020, owing to a decrease in the number of surgical procedures in the country during the pandemic. The decline in the number was due to the restrictions imposed during the pandemic, which resulted in the postponement of surgeries among the patient population.

U.S. Vessel Sealing Devices Market Trends

Increasing Number of Minimally Invasive Surgical Procedures

Minimally invasive surgeries are rapidly increasing owing to their distinct benefits, such as less pain, reduced hospital stay, reduced patient recovery time, and others. Additionally, higher accuracy rate, less scarring, smaller and fewer incisions, and others are some factors fostering the preferential shift toward these surgical procedures. Thus, increasing adoption of these procedures, along with key players focusing on launching advanced vessel sealing devices in the country, is likely to contribute to the growth of the market.

• According to a 2022 news published by The Bone & Joint Surgery Clinic, it was reported that minimally invasive spine surgery has a success rate of around 90%.

U.S. Vessel Sealing Devices Market Growth Factors

Rising Number of Surgeries to Augment the Demand for Vessel Sealing Devices

The rising number of traumatic injuries, such as road accidents, injuries, and others, is resulting in a growing number of patient admissions in hospitals. The rising patient population seeking treatment for disorders, including urological and gynecological, is aiding in the growing number of surgeries among the population. Along with this, the growing awareness about advanced surgical instruments among surgeons and high healthcare expenditure is leading to the rising adoption of these devices among patients. 

• For instance, according to statistics from an article published by the National Center for Biotechnology Information (NCBI), it was reported that about 40.0 to 50.0 million surgeries are performed every year in the U.S.

Moreover, the increasing geriatric population in the country is also driving a large number of surgeries performed annually. The geriatric population is associated with a higher risk of diseases, including diabetes, cardiovascular diseases, neurovascular diseases, injuries, and others, which is contributing to a greater number of surgeries being performed in the country.

In the U.S., approximately 1.6 million hip and knee replacement procedures were performed in 2018, as compared to 2.8 million hip and knee replacement procedures in 2022, and witnessed an increase of 75%.

RESTRAINING FACTORS

High Cost of Bipolar Devices to Limit Market Growth 

The growing adoption of bipolar vessel sealing devices is due to their certain benefits, such as advanced radiofrequency energy to seal blood vessels, among others. However, the high price range associated with bipolar devices is likely to limit the product adoption among surgeons, and impede the U.S. vessel sealing devices market growth. Additionally, the associated high prices with these bipolar devices is due to factors such as shorter operating time, reduced blood loss, and others, further limiting the demand for these devices in the country.

• For instance, according to a 2023 article published by National Center for Biotechnology Information (NCBI), it was reported that the cost of monopolar ligasure maryland jaw thoracic sealer/divider with nano-coating is around USD 745.0 whilst bipolar ligasure blunt tip open and laparoscopic sealer/divider with nano-coating is around USD 800.0.

U.S. Vessel Sealing Devices Market Segmentation Analysis

By Product Analysis

Based on product, the market is segmented into electro-thermal vessel sealer devices, ultra-coagulation shears, and hybrid. The electro-thermal vessel sealer devices segment is further bifurcated into bipolar devices and monopolar devices.

The electro-thermal vessel sealer devices segment held a larger share in 2022 due to the increasing number of products being introduced by key players in the market. Along with this, the efficiency, durability, and technological advancements of these vessel sealing devices are resulting in their higher adoption among surgeons.

• For instance, according to an article published by BMC Surgery in November 2019, approximately 97% efficiency was observed with vessel sealing devices during the surgical procedures in the first attempt itself.

Moreover, the ultra-coagulation shears segment is also expected to grow during the forecast period. The segmental growth is due to certain benefits such as lower heat generation, minimal desiccation and tissue charring, and others resulting in the growing adoption of ultra-coagulation shears in the market.

By Components Analysis

Based on component, the market segments are generators, instruments, and accessories. The instruments segment dominated the market in 2022 owing to the increasing adoption of instruments in hospitals and ambulatory surgical centers, resulting in a growing focus of key players to receive approvals for these instruments in the market.

The generators segment is growing due to the rising number of hospitals adopting generators for their vessel sealing instruments, leading to the growing number of product launches by key players in the market.

• For instance, in January 2021, Bolder Surgical launched CoolSeal generator with an aim to provide instruments for general, urological and gynecological surgery among patients.

By Surgery Type Analysis

Based on surgery type, the market is divided into general surgery and laparoscopic surgery.                                                                              

The general surgery segment accounted for a larger U.S. vessel sealing devices market share in 2022. Rising cases of road accidents and the preference for general surgeries for these patients are some factors contributing to the dominance of the segment. Also, higher penetration of general surgery among emerging countries, is further likely to support the segmental growth.

• For instance, according to the Bureau of Labor Statistics, it was reported that there are over 6.0 million passenger car accidents in the U.S. every year.

By Application Analysis

Based on application, the market is segmented into urology, gynecology, cardiothoracic, gastroenterology, and others.

The cardiothoracic segment dominated the market in 2022. The growing prevalence of cardiothoracic disorders, such as heart failure, among others, is resulting in an increasing number of patient admissions in hospitals. This combined with the increasing number of initiatives for raising awareness about the conditions among the population, is resulting in a growing diagnosis rate of the conditions and higher demand for technologically advanced products for surgeries.

• For instance, according to an article published by the National Center for Biotechnology Information (NCBI), it was reported that approximately 530,000 general thoracic surgery cases are performed yearly in the U.S.

The urology and gastroenterology segments are also growing due to the increasing adoption of vessel sealing devices in gastroenterological surgeries among patients. These factors, along with growing technological advancements, are likely to support the growth of the segments in the market.

By End-user Analysis

Based on end-user, the market is divided into hospital & ASCs, specialty clinics, and others.

The hospitals & ASCs segment dominated in 2022 due to a higher number of ambulatory surgical procedures, expansion of the healthcare sector, and an increase in the number of hospitals & ASCs.  

• For instance, according to the news published by Zippia 2022, there are over 32,876 surgeons currently employed in the U.S. Amongst them, 48.8% of all surgeons are women, while 51.2% are men.  

List of Key U.S. Vessel Sealing Devices Market Companies

A strong distribution network and direct presence of significant market players have been providing opportunities for growth for new players, which is supporting market growth. Key players, including Medtronic, Olympus Corporation, Ethicon, and B. Braun SE, captured a prominent share of the U.S. vessel sealing devices market. The major market share is due to their strong presence, strong basis of innovation, and research & development activities to launch new vessel sealing devices in the market, along with their robust product portfolio.

• For instance, in November 2022, Intuitive Surgical received U.S. FDA approval for the da Vinci E-200 Electrosurgical Generator in order to cater for the growing demand for surgeries among the patient population.

Moreover, the increasing research and development activities are resulting in a growing focus on players receiving approvals for their innovative vessel sealing devices. This, along with a growing number of acquisitions and collaborations among the major players, is also likely to strengthen the presence of players, contributing to the growth of the market.

LIST OF KEY COMPANIES PROFILED:

• Medtronic (Ireland)


• Ethicon US, LLC. (U.S.)


• Olympus Corporation (Japan)


• B. Braun SE (Germany)


• Intuitive Surgical (U.S.)


• CONMED Corporation (U.S.)


• OmniGuide Holdings, Inc. (U.S.)

KEY INDUSTRY DEVELOPMENTS:

• March 2022: CONMED Corporation granted U.S. FDA approval for ElectroSurgical Cutting and Coagulation Device and Accessories in order to support the rising demand for novel surgical instruments among surgeons.


• June 2021: Ethicon expanded its advanced bipolar energy portfolio with the launch of Enseal X1 Curved Jaw Tissue Sealer to increase procedural efficiency.


• December 2020: Olympus Corporation acquired Veran Medical Technologies, Inc., a provider of advanced medical devices, with an aim to strengthen its global position as a medical device company.

REPORT COVERAGE

The U.S. vessel sealing devices market research report provides a detailed analysis of the market. It focuses on key aspects such as technological advancement and emerging trends in energy devices. Additionally, it includes new product launches, key industry developments such as mergers, partnerships, and acquisitions, and the impact of COVID-19 on the market. Besides this, the report also highlights key industry dynamics.

Report Scope & Segmentation